Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Remote control of intestinal tumorigenesis by innate immunity.

Secher T, Gaillot O, Ryffel B, Chamaillard M.

Cancer Res. 2010 Mar 1;70(5):1749-52. doi: 10.1158/0008-5472.CAN-09-3401. Epub 2010 Feb 9. Review.

2.

Innate immunity in Crohn's disease: the reverse side of the medal.

Dessein R, Chamaillard M, Danese S.

J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 1:S144-7. doi: 10.1097/MCG.0b013e3181662c90. Review.

PMID:
18806708
3.

Epithelial NEMO links innate immunity to chronic intestinal inflammation.

Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S, Huth M, Nikolaev A, Neufert C, Madison B, Gumucio D, Neurath MF, Pasparakis M.

Nature. 2007 Mar 29;446(7135):557-61. Epub 2007 Mar 14.

4.

Improved innate immune responses by Frondanol A5, a sea cucumber extract, prevent intestinal tumorigenesis.

Janakiram NB, Mohammed A, Bryant T, Lightfoot S, Collin PD, Steele VE, Rao CV.

Cancer Prev Res (Phila). 2015 Apr;8(4):327-37. doi: 10.1158/1940-6207.CAPR-14-0380. Epub 2015 Feb 5.

5.

Flag in the crossroads: flagellin modulates innate and adaptive immunity.

Gewirtz AT.

Curr Opin Gastroenterol. 2006 Jan;22(1):8-12. Review.

PMID:
16319670
6.

The expression of innate immunity genes in Italian Crohn disease patients.

Milanese M, Segat L, Marziliano N, Crovella S.

Eur J Histochem. 2007 Jul-Sep;51(3):199-202.

PMID:
17921115
7.

[Cancer preventive surgical indications in inflammatory intestinal diseases].

Herfarth C, Otto HF.

Chirurg. 1987 Apr;58(4):221-7. German. No abstract available.

PMID:
3595285
8.

Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88.

Rakoff-Nahoum S, Medzhitov R.

Science. 2007 Jul 6;317(5834):124-7.

9.

Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.

Tlaskalová-Hogenová H, Stepánková R, Hudcovic T, Tucková L, Cukrowska B, Lodinová-Zádníková R, Kozáková H, Rossmann P, Bártová J, Sokol D, Funda DP, Borovská D, Reháková Z, Sinkora J, Hofman J, Drastich P, Kokesová A.

Immunol Lett. 2004 May 15;93(2-3):97-108. Review.

PMID:
15158604
10.

The bile acid receptor FXR is a modulator of intestinal innate immunity.

Vavassori P, Mencarelli A, Renga B, Distrutti E, Fiorucci S.

J Immunol. 2009 Nov 15;183(10):6251-61. doi: 10.4049/jimmunol.0803978. Epub 2009 Oct 28.

11.

Role of the innate immune system in the pathogenesis of inflammatory bowel disease.

van Lierop PP, Samsom JN, Escher JC, Nieuwenhuis EE.

J Pediatr Gastroenterol Nutr. 2009 Feb;48(2):142-51. doi: 10.1097/MPG.0b013e3181821964. Review.

PMID:
19179875
12.

[Risk of cancer in chronic inflammatory bowel diseases].

Fischbach W.

Leber Magen Darm. 1992 May;22(3):96-101. Review. German.

PMID:
1625513
13.

Bacteria in Crohn's disease: mechanisms of inflammation and therapeutic implications.

Balfour Sartor R.

J Clin Gastroenterol. 2007 May-Jun;41 Suppl 1:S37-43. Review. Erratum in: J Clin Gastroenterol. 2007 Jul;41(6):637.

PMID:
17438417
14.

Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model.

Fingleton B, Carter KJ, Matrisian LM.

Cancer Res. 2007 May 15;67(10):4800-6.

15.

'Yin and Yang' in inflammation: duality in innate immune cell function and tumorigenesis.

Khatami M.

Expert Opin Biol Ther. 2008 Oct;8(10):1461-72. doi: 10.1517/14712598.8.10.1461 . Review.

PMID:
18774915
16.

Innate immune signalling at intestinal mucosal surfaces: a fine line between host protection and destruction.

Cario E.

Curr Opin Gastroenterol. 2008 Nov;24(6):725-32. doi: 10.1097/MOG.0b013e32830c4341. Review.

PMID:
19122523
17.

The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis.

Xiao H, Gulen MF, Qin J, Yao J, Bulek K, Kish D, Altuntas CZ, Wald D, Ma C, Zhou H, Tuohy VK, Fairchild RL, de la Motte C, Cua D, Vallance BA, Li X.

Immunity. 2007 Apr;26(4):461-75. Epub 2007 Mar 29.

18.

Impaired innate immunity in Crohn's disease.

Comalada M, Peppelenbosch MP.

Trends Mol Med. 2006 Sep;12(9):397-9. Epub 2006 Aug 4.

PMID:
16890491
19.

[Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia].

Raithel M, Weidenhiller M, Schwab D, Müller S, Hahn EG.

Z Gastroenterol. 2001 Oct;39(10):861-75. Review. German.

PMID:
11605156
20.

At the crossroads of inflammation and cancer.

Clevers H.

Cell. 2004 Sep 17;118(6):671-4. Review.

Supplemental Content

Support Center